17.63% to Target, AlphaValue Maintains ‘”Buy”’ Rating on Hikma Pharmaceuticals (LON:HIK) Shares Today
Hikma Pharmaceuticals (LON:HIK) Rating Reaffirmed Equities researchers at AlphaValue now has a GBX 2616 price target on Hikma Pharmaceuticals (LON:HIK). AlphaValue and their recent price…
